Prodesse
Milwaukee · Founded 1993
About Prodesse
Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications. Prodesse sells three FDA 510(k) cleared products in the United States, and two additional CE-marked products in Europe. The company's products can be used in conjunction with various nucleic acid extraction and real-time PCR (polymerase chain reaction) platforms, including Cepheid's SmartCycler(®) II System.
Company Facts
- Founded: 1993
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: M&A
- Last round: Seed (Jan 2002)
- Website: http://www.prodesse.com
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/prodesse-2757412 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.